{
    "paper_id": "f05ba8754cd311aa796d95ba1f6a279e22980123",
    "metadata": {
        "title": "ARTICLE IN PRESS ScienceDirect Masks and COVID-19 \u0b1d",
        "authors": [
            {
                "first": "Modele",
                "middle": [
                    "+"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Claude",
                "middle": [],
                "last": "Cr\u00e9mieux",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "G\u00e9rard",
                "middle": [],
                "last": "Dubois",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Houssin",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Dominique",
                "middle": [],
                "last": "K\u00e9rouedan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Christine",
                "middle": [],
                "last": "Rouzioux",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "In the context of the current COVID-19 pandemic, many health care professionals exposed to infected patients or contact persons report serious difficulties in accessing masks.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "These reports are surprising because the production of masks is not subject to the high constraints that apply to, for example, vaccines or antiviral drugs.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "This Opinion of the National Academy of Medicine was prepared by its COVID-191 scientific monitoring unit set up on 16 March 2020.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "After a historical reminder of the stocks of masks in France over the last two decades, it makes recommendations on the current management of the mask shortage and to prevent it from recurring in the future.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Since 2001, as part of the preparedness plans for large-scale threats (smallpox, biotox, radiation. . .), the French state has built up strategic stocks in order to protect the health of the population (antibiotics, vaccines, antivirals, needles, iodine tablets, antidotes. . .).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "In 2005, during the avian influenza epizootic and the pandemic threat linked to the H5N1 virus, even though there was no vaccine or antiviral drug available, the French state built up stocks of masks.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "Even if their effectiveness is limited, these masks would, in the event of an epidemic, meet the expectations of health professionals, numerous other professionals and the general public, as there would be no other means of prevention or treatment available 1 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "Two types of masks have been acquired: surgical (or antiprojection) masks, which are medical devices, and CE label respirators FFP2 masks, which are not medical devices but which, because of their aerosol filtration capacity, have a higher effectiveness than surgical masks in protecting exposed caregivers [1] .",
            "cite_spans": [
                {
                    "start": 307,
                    "end": 310,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "Surgical masks have a long shelf life before expiry. In contrast, the manufacturers have set the shelf life of FFP2 masks at five years, due to the gradual weakening of the electrostatic charge that contributes to the filtration effect of this type of mask.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "In September 2009, when the ''flu pandemic'' plan was updated, the doctrine on the use of these masks had been updated by the Committee for the Fight against Influenza placed under the General Directorate of Health (DGS): surgical masks are intended for patients; FFP2 masks are intended for the most exposed professionals, in particular healthcare professionals. Between 2005 and 2009, a stock of surgical masks and FFP2 masks was gradually built up by the State, on shared financing (50 %/50 %) between the State and the Disease Assurance (''Assurance Maladie''). In 2005, in order to allow the creation of these stocks of FFP2 masks, the State had encouraged, through the launch of public contracts, the establishment of a French industrial fabric for the production of masks, with a few companies (Bacou-Dalloz, Macopharma, Paul Boyer, Thuasne. . .).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "Until 2007, the constitution and management of these stocks were ensured by the Ministry of Health (DGS). From 2007 onwards, these stocks were managed by the Establishment for preparation for health emergencies (\u00c9tablissement pour la pr\u00e9paration aux urgences sanitaires, EPRUS), a newly created institution under the supervision of the Ministry of Health.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "In April 2009, when the influenza pandemic caused by the H1N1 virus broke out, the stocks held in France [3] were 1 billion surgical masks (100 % of the estimated need) and 700 million FFP2 masks (80 % of the estimated need). These needs were estimated by taking into account the size of the target populations, the probable duration of the pandemic and the conditions of use of the masks (in particular, the average time a mask is worn).",
            "cite_spans": [
                {
                    "start": 105,
                    "end": 108,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "The value of surgical masks stock was D 40 million in January 2009 and D 32 million in May 2010. The value of the stock of FFP2 masks was D 182 million in January 2009 and D 219 million in May 2010 [3] . https://doi.org/10.1016/j.banm.2020.05.002 0001-4079/ Indeed, during the H1N1 pandemic, surgical masks were released from these stocks for use, whereas due to the low level of concern among healthcare professionals and the population, there was little need to mobilise the stock of FFP2 masks.",
            "cite_spans": [
                {
                    "start": 198,
                    "end": 201,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "Despite this finding on the use of masks during the H1N1 pandemic, the Senate Inquiry Report concluded that, in the face of a serious and unknown virus, reluctance to wear masks would fall and that ''absolute criticism of this effective means of protection should be avoided'' [3] .",
            "cite_spans": [
                {
                    "start": 277,
                    "end": 280,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "Constitution and use of the State's stock of masks in France (2005-2011)"
        },
        {
            "text": "Despite the estimated number of deaths linked to the pandemic due to the H1N1 virus in 2009 (approximately 200,000 worldwide) [4] , the judgements made on the management of the flu pandemic due to the H1N1 virus were rather that WHO and many States, including France, had done too much, particularly with regard to the acquisition of vaccines.",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 129,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "These judgements may have influenced the attitude of scientific bodies and public authorities with regards continuing the preparation for the risk of a pandemic linked to an emerging virus with respiratory tropism.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "Following the health crisis caused by the H1N1 virus, several developments were observed, with changes in the government's attitude towards its stocks, particularly of masks.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "A slight change first occurred in the doctrine on the use of masks, following the opinion of the High Council of Public Health (HCSP) dated 1 July 2011 [5] . Referring to the preventive effectiveness of both surgical masks and FFP2 type masks, ''in the context of a high-risk such as SARS'' [5] , this opinion recommended that:",
            "cite_spans": [
                {
                    "start": 152,
                    "end": 155,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 291,
                    "end": 294,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "\u2022 the surgical mask is worn by sick people, particularly in the healthcare setting; \u2022 the FFP2 mask is made available to healthcare professionals being in a high-risk care situation on a patient's respiratory system (intubation; tracheal suctioning; nasopharyngeal sampling; physiotherapy, etc.); \u2022 the FFP2 mask is worn by the patient's family or friends;",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "\u2022 the FFP2 mask is made available to exposed healthcare professionals (in the case of a highly pathogenic respiratory agent, for healthcare workers at risk of airborne transmission of the agent during an act involving direct contact with a suspect or confirmed case or on entering a room where there is a suspect or confirmed case, regardless of the mode or place of practice) [5] ; \u2022 the surgical mask, and no longer the FFP2 mask, is recommended for professionals (other than healthcare professionals) in counter activity [5] .",
            "cite_spans": [
                {
                    "start": 377,
                    "end": 380,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 524,
                    "end": 527,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "This advice indicated that the stock should therefore be composed of both types of masks, provided information for the calculation of the sizing, including the permanent stock, and suggested ways to avoid a supply disruption [5] .",
            "cite_spans": [
                {
                    "start": 225,
                    "end": 228,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "In the aftermath of the H1N1 flu pandemic and in order to draw lessons from it, the revision of the ''pandemic flu'' strategic plan [6] also led to the development of a new strategy for health-related products stockpilling.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "Based in particular on the HCSP's opinion of 1 July 2011, this new strategy also concerned masks.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "In the framework of this strategy, led by the General Secretariat for Defence and National Security, in conjunction with the ministries concerned, several changes have been made from 2013 onwards. These were analysed in a report by the Senate Finance Committee in 2015 [7] .",
            "cite_spans": [
                {
                    "start": 269,
                    "end": 272,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "One important change, with regard to masks, was that ''the national stock of masks managed by EPRUS would be limited to surgical protective masks, while the stockpiling of masks for the protection of health personnel (in particular FFP2 masks for certain high-risk procedures) was now the responsibility of employers'' [7] .",
            "cite_spans": [
                {
                    "start": 319,
                    "end": 322,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "These shifts resulted in: \u2022 the non-renewal of certain stocks that had reached their expiry date, linked in particular to the transfer of responsibility for building up certain stocks from the State to various employers in the health sector, in particular health establishments or medico-social establishments, in the case of FFP2 protective masks intended for their staff [7] ; \u2022 the smoothing of target stock acquisitions; \u2022 a reorganization of the State's storage logistics between the central platform in Vitry-le-Fran\u00e7ois and the zonal platforms; \u2022 a distinction between ''strategic'' stocks managed by the State at the national level and ''tactical'' resources located in health facilities with SAMU/SMUR, with a view to ''ensuring an early response while awaiting the mobilization, if necessary, of strategic stocks'' [8] ; \u2022 the acquisition of tactical resources was now the responsibility of the health establishments, financed by MIGAC credits [7] ; \u2022 EPRUS support for the management of the resources of the Regional Health Agencies and health establishments, particularly with a view to maintaining and renewing their ''tactical'' stocks.",
            "cite_spans": [
                {
                    "start": 373,
                    "end": 376,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 825,
                    "end": 828,
                    "text": "[8]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 954,
                    "end": 957,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "It can be assumed that an instruction (interministerial circular?) indicated to private health professionals, heads of health establishments and managers of establishments in the medico-social sector that it was their responsibility to have stocks of FFP2 masks for the protection of professionals likely to be exposed. This evolution of the doctrine of use of masks and their stocking strategy has resulted in a strong decrease in stocks since 2010 [7] .",
            "cite_spans": [
                {
                    "start": 450,
                    "end": 453,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "It should be noted that ''the composition and distribution of these stocks constituting sensitive data'', the special rapporteur of the Senate Finance Committee limited himself, in 2015, to an analysis of the evolution of the general value of the State's stocks. The value of these stocks rose from 982 million euros at the end of 2010 to 416 million euros in 2015. The projected expenditures for the government health stock was 33 million euros per year between 2016 and 2018 [7] .",
            "cite_spans": [
                {
                    "start": 477,
                    "end": 480,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "In the same Senate report, regarding the evolution of the strategic stocks of the State concerning Health, a Senator recalled that: ''in periods when no pandemic is raging, such a tool always seems too expensive but, in times of crisis, it is judged that it is not powerful enough'' [7] .",
            "cite_spans": [
                {
                    "start": 283,
                    "end": 286,
                    "text": "[7]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Doctrine of use and stocking strategy of masks between 2011 and 2015"
        },
        {
            "text": "An important change in the governance of State stocks occurred on 1 May 2016, when the InVS, the INPES and the EPRUS were brought together in a single institution: Sant\u00e9 publique France (SPF).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Stocks of masks (2016-2020) and their management during the COVID-19 epidemic"
        },
        {
            "text": "In a chapter on inventories in preparation for pandemic influenza in 2018, mention is made of barrier measures and the ''constitution of a stock of surgical masks'' [8] . No information is provided on the level of inventories, nor on the funding committed. FFP2 masks are not mentioned. No mention is made of any possible support provided by SPF for the stockpiling of FFP2 masks by health facilities, medico-social institutions and private health professionals.",
            "cite_spans": [
                {
                    "start": 165,
                    "end": 168,
                    "text": "[8]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "Stocks of masks (2016-2020) and their management during the COVID-19 epidemic"
        },
        {
            "text": "As the acquisition of FFP2 masks is now the responsibility of these employers (health facilities, medico-social institutions, liberal health professionals), the question arises as to whether, in all professional places in the health sector, the acquisitions necessary for pandemic preparedness have been made satisfactorily and renewed?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Stocks of masks (2016-2020) and their management during the COVID-19 epidemic"
        },
        {
            "text": "In this context, according to the testimonies mentioned in the introduction, the outbreak of the COVID-19 epidemic in February 2020 revealed a shortage of masks, in particular FFP2. The health authorities, faced with this situation and with a view to managing the shortage as well as possible, asked for advice in March 2020:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Stocks of masks (2016-2020) and their management during the COVID-19 epidemic"
        },
        {
            "text": "\u2022 the HCSP's opinion, issued on 14 March 2020, regarding the policy of nationalizing the wearing of masks, specifies the list of invasive acts and maneuvers justifying the wearing of FFP2 mask (not yet public) [10] ; \u2022 the opinion of the French Society of Hospital Hygiene, dated 4 March 2020, specifies the indications for wearing surgical and FFP2 masks [11] ; \u2022 that of the Soci\u00e9t\u00e9 fran\u00e7aise d'hygi\u00e8ne hospitali\u00e8re of 14 March 2020, regarding the conditions for extending the wearing or reuse of surgical and FFP2 masks for healthcare professionals, takes into account ''the need to take into account the availability of masks'' [11] . It concludes that reuse should be avoided, that the duration of use can be extended up to 4 h for a surgical mask and up to 8 h for an FFP2 mask, and that the use of other types of masks is not recommended.",
            "cite_spans": [
                {
                    "start": 210,
                    "end": 214,
                    "text": "[10]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 356,
                    "end": 360,
                    "text": "[11]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 632,
                    "end": 636,
                    "text": "[11]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "Stocks of masks (2016-2020) and their management during the COVID-19 epidemic"
        },
        {
            "text": "In the current situation of a shortage of masks for healthcare professionals, the allocation of masks available in France must give priority to the most exposed professionals, i.e. healthcare professionals. Among healthcare professionals, the allocation of available FFP2 masks must go:",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Management of mask shortage"
        },
        {
            "text": "\u2022 as a priority, to healthcare professionals carrying out the procedures most at risk of virus transmission (intubation/extubation, mechanical ventilation with an ''open'' expiratory circuit or non-invasive mechanical ventilation, tracheal suctioning, physiotherapy, aerosol therapy, bronchial fibroscopy, nasal or nasopharyngeal sampling, autopsy). These procedures must be performed by a health professional equipped with an FFP2 type mask and not a surgical anti-projection mask; \u2022 then, to professionals in health care institutions in charge of care or in close contact with people who are ill because of COVID-19 or people suspected of being ill; -and to health professionals (doctors, nurses, assistant nurses, ambulance drivers, etc.) in close contact with people suspected of being ill with COVID-19, in the private sector care, in medical-social institutions the or at home.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Management of mask shortage"
        },
        {
            "text": "For the most exposed healthcare professionals, only FFP2 type masks, offering a certain filtration capacity and a certain degree of tightness, can reduce the risk of contamination. Surgical splash-proof masks do not provide this protection, whether they are made of fabric or paper, even if they are washed or disinfected.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Management of mask shortage"
        },
        {
            "text": "Health care and social care facilities, faced with the shortage of FFP2 masks, should not produce local guidelines which, by deviating from national guidelines, could lead to a false sense of security, particularly for those carers exposed during the most high-risk procedures.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Management of mask shortage"
        },
        {
            "text": "In order to avoid such shortages in the future, the strategy for storing masks, particularly FFP2 type masks, should be reviewed so that the State can build up a strategic stock of this type of mask, which might be mobilized urgently from the national platform or zonal platforms, and which might be sized and renewed in order to cover needs during the first weeks of an epidemic. This sizing must take into account all the target populations identified in the framework of the doctrine on the use of these masks.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prevention of mask shortages"
        },
        {
            "text": "Without relieving health establishments, medico-social establishments and professionals in the liberal sector of their responsibility towards their staff, this storage of masks by the State will make it possible to better respond to a large-scale epidemic, such as the pandemic at COVID-19. This new storage strategy will make it possible to better cope in circumstances in which the seriousness of the epidemic would make it necessary to extend the use of FFP2 masks to professionals in continuity of activity in counter, reception or security positions, or to intensify barrier measures by encouraging wider use of surgical anti-projection masks in the general population.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prevention of mask shortages"
        },
        {
            "text": "This new storage strategy will help maintain production capacity for these masks on national territory. The storage of surgical anti-projection masks and FFP2 type masks, as part of the preparation for a pandemic with an emerging virus with respiratory tropism, must finally be closely and regularly monitored by Parliament in order to ensure transparent monitoring of the evolution of mask stocks by nature and quantity. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prevention of mask shortages"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Avis d'expert relatif \u00e0 la strat\u00e9gie de constitution d'un stock de contre-mesures m\u00e9dicales face \u00e0 une pand\u00e9mie grippale",
            "authors": [
                {
                    "first": "France",
                    "middle": [],
                    "last": "Sant\u00e9 Publique",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Rapport fait au nom de la Q6 commission d'enqu\u00eate sur la mani\u00e8re dont a \u00e9t\u00e9 programm\u00e9e, expliqu\u00e9e et g\u00e9r\u00e9e la campagne de vaccination contre la grippe A(H1N1)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Assembl\u00e9e Nationale",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Door",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Rapport de la Commission d'enqu\u00eate sur le r\u00f4le des firmes pharmaceutiques dans la gestion par le Gouvernement de la grippe A(H1N1), cr\u00e9\u00e9e sur la demande du groupe Communiste, R\u00e9publicain et Citoyen et des s\u00e9nateurs du Parti de Gauche, dont la Conf\u00e9rence (S\u00e9nat)",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Autain",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Milon",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "S"
                    ],
                    "last": "Dawood",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Iuliano",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Reed",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "I"
                    ],
                    "last": "Meltzer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Shay",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "Y"
                    ],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Lancet Infect Dis",
            "volume": "12",
            "issn": "",
            "pages": "687--95",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Avis relatif \u00e0 la strat\u00e9gie \u00e0 adopter concernant le stock \u00c9tat de masques respiratoires",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Haut Conseil De La Sant\u00e9 Publique",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Rapport d'information n o 625. L'\u00c9tablissement de pr\u00e9paration et de r\u00e9ponse aux urgences sanitaires (EPRUS) : comment investir dans la s\u00e9curit\u00e9 sanitaire de nos concitoyens ?",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "S\u00e9ant ; Delattre",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "/ 327 du 21 ao\u00fbt 2013 relative au dispositif de stockage et de distribution des produits de sant\u00e9 des stocks strat\u00e9giques de l'\u00c9tat pour r\u00e9pondre \u00e0 une situation sanitaire exceptionnelle",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Circulaire Interminist\u00e9rielle N O Dgs/Dus/Dgscgc/",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Rapport annuel",
            "authors": [
                {
                    "first": "France",
                    "middle": [],
                    "last": "Sant\u00e9 Publique",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Avis relatif \u00e0 la politique de rationalisation du port du masque",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Avis pr\u00e9cisant les indications des ports des masques chirurgicaux anti-projection et des masques de protection filtrant de type FFP",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Soci\u00e9t\u00e9 Fran\u00e7aise D&apos;hygi\u00e8ne Hospitali\u00e8re",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {},
    "back_matter": []
}